DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Obestin-30 is a drug marketed by Ferndale Labs and is included in one NDA.
The generic ingredient in OBESTIN-30 is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.
A generic version of OBESTIN-30 was approved as phentermine hydrochloride by ELITE LABS INC on May 30th, 1997.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Ferndale Labs||OBESTIN-30||phentermine hydrochloride||CAPSULE;ORAL||087144-001||Approved Prior to Jan 1, 1982||DISCN||No||No||⤷ Try it Free||⤷ Try it Free||⤷ Try it Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|